fda compounding glp 1 Proposes Ban on Bulk for Semaglutide, Tirzepatide, and Liraglutide What Are Compounded GLP-1 Medications?

However, it is essential to note that when additional pharmacological intervention is required to control diabetes mellitus, the choice between SGLT-2 inhibitors and GLP-1 RAs should be based on the patients individual needs and the specific medications already being used

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis

Some providers offer this option

More common during rapid dose escalation

#GLP1 #Type2Diabetes #ObesityCare #MetabolicHealth #HealthPolicy -1 :

Diabetes 54:34273434 Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G et al (2016) Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study